
Vaccine maker AstraZeneca has admitted for the first time in a British court that its COVID-19 vaccine may cause rare side effects like TTS. TTS i.e. Thrombocytopenia Syndrome causes blood clotting in the body. The person suffering from this may suffer serious problems like stroke, heart failure, etc.
In documents presented in the British High Court, AstraZeneca has admitted the side effects. However, even after accepting the side effects caused by the vaccine, the company is opposing claims of diseases or ill effects caused by it. This news is also very important for India because, during the spread of Covid-19, the same Oxford-AstroZeneca vaccine was used on a large scale here under the name of Covishield.
Indian company Serum Institute of India produced this vaccine in the country under the license obtained from AstraZeneca and it was not only used in India's Covid vaccination campaign but was also exported to many countries of the world. Apart from Covishield, this vaccine was also sold under the brand name Vaxjaveria in many countries. This lawsuit against AstraZeneca has been filed by Jamie Scott, who suffered brain damage after taking this vaccine. Many families have also complained about the side effects of this vaccine in court.
Demand compensation from the company
The complainants who reached the court have demanded compensation from the company for the damage caused to the body. The special thing is that Britain has now banned this vaccine due to security reasons. After this acceptance of the company, the number of people demanding compensation may also increase.
Lawsuits can start in India also
After Covid in India, the number of such deaths had increased significantly for which the cause was not known. Most of these were linked to some physical problem or the other and the government and the health world never believed that this could happen due to the side effects of the Covid vaccine. Now after this acceptance of the company, a round of lawsuits is likely to start in India also.
Some vaccines can cause blood clotting disease
Medical expert Dr. Rajeev Jayadevan has said that in rare cases, Thrombosis Thrombocytopenia Syndrome (TTS) may occur after the use of some vaccines. His statement comes after pharmaceutical company AstraZeneca admitted before the court that the Covid vaccines developed by it, Covishield and Vaxzeveria, can cause TTS in some cases.
TTS is related to the formation of clots in the blood vessels of the brain or other internal organs and low platelet count. AstraZeneca developed anti-Covid vaccines with Oxford University. In many British media reports, the company's vaccine has been accused of causing serious diseases and deaths. These types of reports have been published in many reputed magazines. Jayadevan, co-chairman of the National Indian Medical Association (IMA) Covid task force in Kerala, said that although Covid vaccines have helped prevent many deaths, side effects cannot be ruled out agency.
Rarely do such conditions develop: WHO
However, WHO has said regarding adenovirus vector vaccines that such conditions rarely develop. Serum Institute of India produced an anti-Covid-19 vaccine called Covishield but did not use the mRNA platform. It has been prepared using the viral vector platform. The vaccine uses a chimpanzee adenovirus modified to make it capable of carrying the COVID-19 spike protein into human cells.
Police in Sindhudurg district of Maharashtra have registered a case against the contractor and st
The T20 World Cup is just a few days away. The tournament will be jointly hosted by India and Sri
A video is becoming increasingly viral on social media, in which Salman Khan is seen. Bhaijaan su
Indian team's fast bowler Mohammed Shami's troubles have increased. The Calcutta High Court has o
'Conspiracy to weaken democracy', BJP cornered Rahul Gandhi over US aid; Know the truth
The BJP on Thursday said that US President Donald Trump's remarks on USAID funding to India confi
In the current cricketing landscape, taking Vaibhav Suryavanshi's wicket has become a monumental
iQOO Z11xa 5G First Sale Today: 7200mAh Battery and 50MP Camera, Check ₹28,999 Price
iQOO has started selling its new iQOO Z11xa 5G smartphone in India from today, September 14. The
GST 2.0 rates came into effect today, what will be the benefits and impact? Understand in 10 points.
A major change has been implemented in the Goods and Services Tax (GST) from today. The new GST r
Sunrisers Hyderabad lost the match against Gujarat on Sunday. The guests defeated them by seven w
Before the first session of the 18th Lok Sabha, Prime Minister Narendra Modi presented his views